| pubmed-article:15685041 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C0279637 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C1704628 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C1298613 | lld:lifeskim |
| pubmed-article:15685041 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:15685041 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15685041 | pubmed:dateCreated | 2005-2-1 | lld:pubmed |
| pubmed-article:15685041 | pubmed:abstractText | The purpose of this study was to investigate in a randomized way the clinical benefit of addition of intracavitary hyperthermia (ICHT) to a conventional chemoradiotherapy schedule in patients with T2-T3N0M0 anal cancer. | lld:pubmed |
| pubmed-article:15685041 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15685041 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15685041 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15685041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15685041 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15685041 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15685041 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15685041 | pubmed:issn | 1537-453X | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:VlahosLambros... | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:PlataniotisGe... | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:UzunogluNikol... | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:VassilisKoulo... | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:KouvarisJohnJ | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:GennatasCosta... | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:DardoufasCost... | lld:pubmed |
| pubmed-article:15685041 | pubmed:author | pubmed-author:PapavasiliouC... | lld:pubmed |
| pubmed-article:15685041 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15685041 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:15685041 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15685041 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15685041 | pubmed:pagination | 91-9 | lld:pubmed |
| pubmed-article:15685041 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:meshHeading | pubmed-meshheading:15685041... | lld:pubmed |
| pubmed-article:15685041 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15685041 | pubmed:articleTitle | Chemoradiotherapy combined with intracavitary hyperthermia for anal cancer: feasibility and long-term results from a phase II randomized trial. | lld:pubmed |
| pubmed-article:15685041 | pubmed:affiliation | Aretaieion University Hospital, Radiology Department, Athens, Greece. vkouloul@cc.ece.ntua.gr | lld:pubmed |
| pubmed-article:15685041 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15685041 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15685041 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15685041 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15685041 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15685041 | lld:pubmed |
